The Gross Margin of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (688505.SS) is 91.05%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 91.05% |
| 2023-12-31 | 91.29% |
| 2022-12-31 | 91.63% |
| 2021-12-31 | 92.89% |
| 2020-12-31 | 92.31% |
| 2019-12-31 | 92.50% |
| 2018-12-31 | 90.36% |
| 2017-12-31 | 90.42% |